» Articles » PMID: 23164007

Treatment of Necrotizing Enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic Review

Overview
Journal J Pediatr Surg
Date 2012 Nov 21
PMID 23164007
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The optimal treatment of necrotizing enterocolitis (NEC) is a common challenge for pediatric surgeons. Although many studies have evaluated prevention and medical therapy for NEC, few guidelines for surgical care exist. The aim of this systematic review is to review and evaluate the currently available evidence for the surgical care of patients with NEC.

Methods: Data were compiled from a search of PubMed, OVID, the Cochrane Library database, and Web of Science from January 1985 until December 2011. Publications were screened, and their references were hand-searched to identify additional studies. Clinicaltrials.gov was also searched to identify ongoing or unpublished trials. The American Pediatric Surgical Association Outcomes and Clinical Trials Committee proposed six questions deemed pertinent to the surgical treatment of NEC. Recent Cochrane Reviews examined three of these topics; a literature review was performed to address the additional three specific questions.

Results: The Cochrane Reviews support the use of prophylactic probiotics in preterm infants less than 2500 grams to reduce the incidence of NEC, as well as the use of human breast milk rather than formula when possible. There is no clear evidence to support delayed initiation or slow advancement of feeds. For surgical treatment of NEC with perforation, there is no clear support of peritoneal drainage versus laparotomy. Similarly, there is a lack of evidence comparing enterostomy versus primary anastomosis after resection at laparotomy. There are little data to determine the length of treatment with antibiotics to prevent recurrence of NEC.

Conclusion: Based on available evidence, probiotics are advised to decrease the incidence of NEC, and human milk should be used when possible. The other reviewed questions are clinically relevant, but there is a lack of evidence-based data to support definitive recommendations. These areas of NEC treatment would benefit from future investigation.

Citing Articles

The clinical characteristics and risk factors analysis within one week before the onset of necrotizing enterocolitis.

Li L, Sun W, Cai Y, Feng Z, Yu Y, Yang Z Sci Rep. 2024; 14(1):22380.

PMID: 39333703 PMC: 11436905. DOI: 10.1038/s41598-024-73212-2.


A quality improvement initiative standardizing the antibiotic treatment and feeding practices in patients with medical necrotizing enterocolitis.

Mahmood Z, ODonnell B, Brozanski B, Vats K, Kloesz J, Jackson L J Perinatol. 2023; 44(4):587-593.

PMID: 37863983 DOI: 10.1038/s41372-023-01797-z.


Necrotizing enterocolitis, gut microbes, and sepsis.

Duess J, Sampah M, Lopez C, Tsuboi K, Scheese D, Sodhi C Gut Microbes. 2023; 15(1):2221470.

PMID: 37312412 PMC: 10269420. DOI: 10.1080/19490976.2023.2221470.


Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders.

Cerdo T, Garcia-Santos J, Rodriguez-Pohnlein A, Garcia-Ricobaraza M, Nieto-Ruiz A, Bermudez M Nutrients. 2022; 14(21).

PMID: 36364953 PMC: 9658482. DOI: 10.3390/nu14214691.


Probiotic sepsis in preterm neonates-a systematic review.

Kulkarni T, Majarikar S, Deshmukh M, Ananthan A, Balasubramanian H, Keil A Eur J Pediatr. 2022; 181(6):2249-2262.

PMID: 35348825 DOI: 10.1007/s00431-022-04452-5.